The stock price’s performance over the year has been unpredictable, resulting in a mix of pessimistic and optimistic outlooks among investors. Year to date metric has recorded a loss of -36.45%.However, over the last six months, we can see a stronger performance of -49.49%. Over the last 30 days, the price of SNTI has leaped by -29.89%. And in the last five days, it has fallen by -10.86%.
At present, Senti Biosciences Inc (SNTI) has a stock price of $1.97. In the previous session, the stock saw a rise, peaking at $15.0 after an opening price of $1.99. The day’s lowest price was $12.0, and it closed at $2.13.
Senti Biosciences Inc’s market performance has been unstable in recent times. The company’s stock hit a 1-year high of $16.94 on 12/02/24 and a low of $1.52 for the same time frame on 08/07/24.
52-week price history of SNTI Stock
Analyzing a stock’s 52-week high and low prices can offer important information about its present condition and future outlook. Senti Biosciences Inc’s current trading price is -88.37% away from its 52-week high, while its distance from the 52-week low is 29.60%. The stock’s price range during this period has varied between$1.52 and $16.94. The Senti Biosciences Inc’s shares, which operate in the Healthcare, saw a trading volume of around 5.58 million for the day, a figure considerably higher than their average daily volume of 0.23 million over last three months.
Market Capitalization vs. Financial Performance: A Comparative Study
Senti Biosciences Inc (SNTI) has experienced a quarterly decline of -31.60% in its revenues when compared to the same period in the previous year. Presently, the company has a total market capitalization of 51.38M and boasts a workforce of 34 employees.
Combining Moving Average and Trading Volume Data for Better Market Insight
Based on Barchart.com data, the company’s moving average over the 100-day period was 3.18, with a change in price of -2.25. Similarly, Senti Biosciences Inc recorded 211,466 in trading volume during the last 100 days, posting a change of -53.29%.
SNTI’s Debt-to-Equity Ratio Cause for Concern? An In-Depth Look
The debt-to-equity (D/E) ratio is a significant metric that provides insights into a company’s financial state and market presence. By dividing a company’s current liabilities by its shareholders’ equity, the D/E ratio depicts the extent of debt used by a company to fund its assets relative to the value of its shareholders’ equity. At the time of writing, the total D/E ratio for SNTI stands at 0.86. Similarly, the long-term debt-to-equity ratio is also 0.73.
SNTI Stock Stochastic Average
As of today, Senti Biosciences Inc’s raw stochastic average for the last 50 days stands at 9.74%. This is a decline compared to the raw stochastic average of the previous 20 days, which was noted at 12.64%. Furthermore, the company’s Stochastic %K and %D values for the past 20 days were 18.66% and 22.54%, respectively.
